RHO and breast cancer: A P132L mutation in caveolin-1 confers a dominant-negative effect on invasiveness of human schirrhous breast cancers [55] and upregulates genes involved in invasiveness and metastasis, including Rho-related signaling molecules and genes expressed by stem cells [56].